- Home
- VKTX vs MAIN Comparison
VKTX vs MAIN Comparison
Compare VKTX & MAIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VKTX
- MAIN
- Stock Information
- Founded
- VKTX 2012
- MAIN 2007
- Country
- VKTX United States
- MAIN United States
- Employees
- VKTX N/A
- MAIN N/A
- Industry
- VKTX Biotechnology: Pharmaceutical Preparations
- MAIN Finance/Investors Services
- Sector
- VKTX Health Care
- MAIN Finance
- Exchange
- VKTX Nasdaq
- MAIN Nasdaq
- Market Cap
- VKTX 4.7B
- MAIN 4.5B
- IPO Year
- VKTX 2015
- MAIN 2007
- Fundamental
- Price
- VKTX $32.87
- MAIN $60.83
- Analyst Decision
- VKTX Strong Buy
- MAIN Hold
- Analyst Count
- VKTX 12
- MAIN 5
- Target Price
- VKTX $106.75
- MAIN $48.80
- AVG Volume (30 Days)
- VKTX 3.5M
- MAIN 557.8K
- Earning Date
- VKTX 02-05-2025
- MAIN 02-27-2025
- Dividend Yield
- VKTX N/A
- MAIN 6.91%
- EPS Growth
- VKTX N/A
- MAIN 11.78
- EPS
- VKTX N/A
- MAIN 5.51
- Revenue
- VKTX N/A
- MAIN $529,897,000.00
- Revenue This Year
- VKTX N/A
- MAIN $10.58
- Revenue Next Year
- VKTX N/A
- MAIN $5.22
- P/E Ratio
- VKTX N/A
- MAIN $11.04
- Revenue Growth
- VKTX N/A
- MAIN 9.27
- 52 Week Low
- VKTX $20.92
- MAIN $43.90
- 52 Week High
- VKTX $99.41
- MAIN $60.89
- Technical
- Relative Strength Index (RSI)
- VKTX 26.61
- MAIN 72.81
- Support Level
- VKTX $32.51
- MAIN $57.05
- Resistance Level
- VKTX $43.55
- MAIN $60.19
- Average True Range (ATR)
- VKTX 2.15
- MAIN 0.95
- MACD
- VKTX -0.41
- MAIN 0.10
- Stochastic Oscillator
- VKTX 17.78
- MAIN 96.18
About VKTX Viking Therapeutics Inc.
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.
About MAIN Main Street Capital Corporation
Main Street Capital Corp is an investment firm engaged in providing customized debt and equity financing to lower middle market companies and debt capital to middle market companies. The investment portfolio of the company is typically made to support management buyouts, recapitalizations, growth financings, refinancing's, and acquisitions of companies that operate in diverse industry sectors. The group invests in secured debt investments, equity investments, warrants, and other securities of the lower middle market and middle market companies based in the United States. Business functioned through the U.S. region and it derives the majority of its income from the source of fees, commission, and interest.